These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7914841)

  • 1. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
    Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
    Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation.
    Diez-Ruiz A; Kaiser G; Jäger H; Birkmann J; Tilz GP; Wachter H; Fuchs D
    Int Arch Allergy Immunol; 1993; 102(1):56-60. PubMed ID: 8104576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
    Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
    Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
    Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
    Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
    Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
    Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers for disease progression in intravenous drug users infected with HIV-1.
    Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H
    AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study.
    Stein DS; Lyles RH; Graham NM; Tassoni CJ; Margolick JB; Phair JP; Rinaldo C; Detels R; Saah A; Bilello J
    J Infect Dis; 1997 Nov; 176(5):1161-7. PubMed ID: 9359714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss in HIV-1 infection is associated with immune activation.
    Zangerle R; Reibnegger G; Wachter H; Fuchs D
    AIDS; 1993 Feb; 7(2):175-81. PubMed ID: 8096702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections.
    Nordøy I; Aukrust P; Müller F; Frøland SS
    Clin Immunol Immunopathol; 1996 Oct; 81(1):16-21. PubMed ID: 8808636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation markers and AIDS prognosis.
    Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
    AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.
    Bass HZ; Nishanian P; Hardy WD; Mitsuyasu RT; Esmail E; Cumberland W; Fahey JL
    Clin Immunol Immunopathol; 1992 Jul; 64(1):63-70. PubMed ID: 1376654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
    Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
    Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.
    Zangerle R; Fuchs D; Reibnegger G; Werner-Felmayer G; Gallati H; Wachter H; Werner ER
    Immunobiology; 1995 Jun; 193(1):59-70. PubMed ID: 7590863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.